Prediction of time-dependent CYP3A4 drug–drug interactions by physiologically based pharmacokinetic modelling: Impact of inactivation parameters and enzyme turnover-Reference-Cited by-同舟云学术

Prediction of time-dependent CYP3A4 drug–drug interactions by physiologically based pharmacokinetic modelling: Impact of inactivation parameters and enzyme turnover

Published:2011-06 Issue:3 Volume:43 Page:160-173
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Rowland Yeo K.,Walsky R.L.,Jamei M.,Rostami-Hodjegan A.,Tucker G.T.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference124 articles.

1. The influence of dose and ethnic origins on the pharmacokinetics of nifedipine;Ahsan;Clin. Pharmacol. Ther.,1993

2. Midazolam kinetics;Allonen;Clin. Pharmacol. Ther.,1981

3. Effect of venlafaxine on the pharmacokinetics of alprazolam;Amchin;Psychopharmacol. Bull.,1998

4. Intersubject and dose-related variability after intravenous administration of erythromycin;Austin;Br. J. Clin. Pharmacol.,1980

5. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties;Austin;Drug Metab. Dispos.,2002

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trial Data-Driven Risk Assessment of Drug–Drug Interactions: A Rapid and Accurate Decision-Making Tool;Clinical Pharmacokinetics;2024-08

2. In Vitro Assessment of Inhibitory Effects of Kinase Inhibitors on CYP2C9, 3A and 1A2: Prediction of Drug-Drug Interaction Risk with Warfarin and Direct Oral Anticoagulants;European Journal of Pharmaceutical Sciences;2024-08

3. A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator;CPT: Pharmacometrics & Systems Pharmacology;2024-07-18

4. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

5. Docetaxel, cyclophosphamide, and epirubicin: application of PBPK modeling to gain new insights for drug-drug interactions;Journal of Pharmacokinetics and Pharmacodynamics;2024-03-30